Endocytosis following dopamine D

Molecular psychiatry (2016-12-07)

N Shioda, Y Yabuki, Y Wang, M Uchigashima, T Hikida, T Sasaoka, H Mori, M Watanabe, M Sasahara, K Fukunaga

RÉSUMÉ

Aberrant dopamine D

MATÉRIAUX

Référence du produit

Marque

Description du produit

Sigma-Aldrich

MISSION^® pLKO.1-puro Non-Mammalian shRNA Control Plasmid DNA, Targets no known mammalian genes

Sigma-Aldrich

MISSION^® esiRNA, targeting human DRD2

Sigma-Aldrich

MISSION^® esiRNA, targeting human PDGFRB